Skip to main navigation Skip to search Skip to main content

Author Correction: Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models (Nature Biotechnology, (2023), 41, 3, (399-408), 10.1038/s41587-022-01520-x)

  • IMI DIRECT Consortium
  • Novo Nordisk Foundation Center for Protein Research
  • Technical University of Denmark
  • University of Copenhagen
  • National Research Council of Italy
  • University of Oxford
  • University of Geneva
  • Newcastle University
  • Helmholtz Zentrum München - German Research Center for Environmental Health
  • Technical University of Munich
  • KTH Royal Institute of Technology
  • Sanofi-Aventis
  • Novo Nordisk Foundation Center for Basic Metabolic Research
  • University of Exeter
  • School of Medicine Centre for Cardiovascular and Lung Biology, Division of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital & Medical School, Dundee, UK
  • University of Westminster
  • Imperial College London
  • Vrije Universiteit Amsterdam
  • Leiden University Medical Center
  • Université de Lille
  • 6MRC Epidemiology Unit, Cambridge, United Kingdom
  • University of Eastern Finland
  • Newcastle Neonatal Service, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals National Health Service (NHS) Foundation Trust, Newcastle upon Tyne, United Kingdom
  • Lund University
  • Eli Lilly Regional Operations
  • Harvard University
  • National University of Singapore
  • University of Ljubljana
  • Genentech Incorporated
  • University of Milan
  • Institut de Recherches Servier
  • Royal Devon & Exeter NHS Foundation Trust
  • Boehringer Ingelheim GmbH
  • University of Bath
  • Saarland University
  • Eli Lilly
  • Ulm University
  • German Center for Diabetes Research (DZD), Muenchen-Neuherberg, Germany
  • Lilly Deutschland GmbH, Bad Homburg, Germany
  • University of Tübingen
  • Centre for Genomic Regulation
  • Universite de Geneve Faculte de Medecine
  • Medical School
  • Aventis Pharma Germany GmbH
  • University of Exeter Medical School
  • Clinical Genetics, Ninewells Hospital & Medical School, Dundee, UK
  • VU University Medical Hospital
  • Leiden University
  • Royal Victoria Infirmary
  • Harvard School of Public Health
  • International Centre for Rural Health of the San Paolo Hospital
  • German Center for Diabetes Research
  • Lilly Deutschland GmbH

Research output: Contribution to journalComment/Letter to the editorAcademic

19 Downloads (Pure)

Abstract

Correction to: Nature Biotechnology. Published online 2 January 2023. In the version of this article initially published, Cristina Leal Rodríguez (Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark) was omitted from the author list. The error has been corrected in the HTML and PDF versions of the article.

Original languageEnglish
Pages (from-to)1026
Number of pages1
JournalNature biotechnology
Volume41
Issue number7
Early online date2023
DOIs
Publication statusPublished - Jul 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Author Correction: Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models (Nature Biotechnology, (2023), 41, 3, (399-408), 10.1038/s41587-022-01520-x)'. Together they form a unique fingerprint.

Cite this